Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Updated: Oct 7 2021

Hepatitis C Drugs

5.0

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(1)

  • Snapshot
    • A 54-year-old man presents to his primary care physician with fatigue and issues with sleep. His symptoms are associated with nausea and abdominal discomfort. A few days ago, he noted dark urine but denies any dysuria. He said that in the past he experienced severe right upper quadrant pain and jaundice approximately 8 years ago, requiring treatment which he does not remember the specifics. Social history is remarkable for intravenous drug use and had required a transfusion over a decade ago. Laboratory testing is remarkable for slightly elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST) level. He has a reactive HCV antibody and positive HCV RNA test. He is started on sofosbuvir-ledipasvir for chronic HCV infection.
  • Introduction
    • Note that none of these medications are used as monotherapy
      • Hepatitis C Drugs
      • Medications
      • Comments
      • Ledipasvir
      • Mechanism of action
        • hepatitis C virus (HCV)
          • NS5A protein inhibitorNS5A is an HCV viral phosphoprotein that is necessary for viral replication
      • Clinical use
        • HCV chronic infection
      • Adverse effects
        • headache
        • weakness
        • fatigue
      • Ribavirin
      • Mechanism of action
        • inosine monophosphate dehydrogenase competitive inhibitor
          • impairs viral DNA and RNA replication
      • Clinical use
        • HCV chronic infection
      • Adverse effects
        • hemolytic anemia
        • severe teratogen
      • Simeprevir
      • Mechanism of action
        • HCV protease (NS3/4A) inhibitor
          • NS3/4A is also essential for viral replication
          • this is a specifically targeted antiviral therapy for HCV
      • Clinical use
        • HCV chronic infection
      • Adverse effects
        • photosensitivity reactions
        • rash
      • Sofosbuvir
      • Mechanism of action
        • inhibits HCV RNA-dependent RNA polymerase (NS5B), which is also essential for viral replication
      • Clinical use
        • HCV chronic infection
      • Adverse effects
        • headache
        • fatigue
        • nausea
    • Mechanism of action
      • inosine monophosphate dehydrogenase competitive inhibitor
        • impairs viral DNA and RNA replication
    • Clinical use
      • HCV chronic infection
    • Adverse effects
      • hemolytic anemia
      • severe teratogen
    • Mechanism of action
      • HCV protease (NS3/4A) inhibitor
        • NS3/4A is also essential for viral replication
        • this is a specifically targeted antiviral therapy for HCV
    • Clinical use
      • HCV chronic infection
    • Adverse effects
      • photosensitivity reactions
      • rash
    • Mechanism of action
      • inhibits HCV RNA-dependent RNA polymerase (NS5B), which is also essential for viral replication
    • Clinical use
      • HCV chronic infection
    • Adverse effects
      • headache
      • fatigue
      • nausea
Card
1 of 0
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options